Stockreport
4 Biotech Stocks to Watch for Potential Upside in 2026 [Yahoo! Finance]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong fourth-quarter results, better visibility, new drug approvals and encouraging pipeline progress have helped the sector sustain momentum even amid regulatory challenges and pricing pressures. Given the continuous need for innovative medical treatments (regardless of the state of the economy), the dynamic biotech industry should continue to capture investors' interest going forward. The recent pickup in mergers and acquisitions (M&A) activity after a period of slowdown, driven by an evolving industry landscape and increasing focus on AI-driven drug discovery, has further supported sector momentum. Large pharmaceutical and biotechnology companies are continually expanding their product portfolios and pipelines through strategic collaborations and acquisitions to adapt their business models amid growing generic competition for key drugs. Consequently, smaller biot
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Two major drug companies are the latest to join TrumpRx [FOX Business Network][FOX Business Network]
- Rapid Micro Biosystems Q4 Earnings Call Highlights [Yahoo! Finance][Yahoo! Finance]
- Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha][Seeking Alpha]
- Amgen (AMGN) is now covered by Jefferies Financial Group Inc.. They set a "hold" rating and a $350.00 price target on the stock.[MarketBeat]
- More
AMGN
SEC Filings
SEC Filings
- 3/6/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- AMGN's page on the SEC website
- More